Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by
chronic comorbidities including cardiovascular diseases, chronic kidney disease, and …

With the aging of the world's population, a large proportion of patients seen in
cardiovascular practice are older adults, but many patients also exhibit signs of physical …

Sarcopenia is a progressive and generalized loss of skeletal muscle mass and function. The
prevalence of sarcopenia was reported to be up to 29% in older persons in the community …

The term sarcopenia was introduced in 1988. The original definition was a “muscle loss” of
the appendicular muscle mass in the older people as measured by dual energy x‐ray …

Sarcopenia, a geriatric disease characterized by a progressive loss of skeletal muscle mass
and loss of muscle function, constitutes a rising, often undiagnosed health problem. Its …

Sarcopenia is a progressive and generalised skeletal muscle disorder involving the
accelerated loss of muscle mass and function that is associated with increased adverse …

Background Osteosarcopenia, the presence of osteopenia/osteoporosis and sarcopenia, is
an emerging geriatric giant, which poses a serious global health burden. Methods and …

To date, sarcopenia is considered a patient-specific imaging biomarker able to predict
clinical outcomes. Several imaging modalities, including dual-energy X-ray absorptiometry …

Many patients with cancer experience poor nutritional status, which detrimentally impacts
clinical outcomes. Poor nutritional status in cancer is primarily manifested by severe muscle …

Background A lack of agreement on definitions and terminology used for nutrition-related
concepts and procedures limits the development of clinical nutrition practice and research …